Estrogen decline during menopause alters fat, muscle, and lipid metabolism; multimodal lifestyle strategies help reduce cardiovascular risk.
Brooke Aggarwal, EdD, MS, FAHA
Advertisement
Brooke Aggarwal, EdD, MS, FAHA
Associate Professor of Medical Sciences, Division of Cardiology, Department of Medicine
Director of Training, Go Red for Women Strategically Focused Research Network at CUMC
Principal Investigator, Go Red for Women Strategically Focused Research Network at CUMC
Columbia University Irving Medical Center
New York, New York
Articles by Brooke Aggarwal, EdD, MS, FAHA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
2
Estrogen therapy shows mixed mental health effects in menopause
3
Earlier menopause, reduced cardiac function jointly linked to poorer brain health in women
4
Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD
5
